The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Pharmacyclics competitive analysis

Loading summary...

Latest patents of Pharmacyclics opposed by its competitors

Explore Pharmacyclics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3265084
Nov 22, 2023Pharmaceutical Formulations Of Bruton'S Tyrosine Kinase Inhibtor1
EP3033079
Oct 31, 2018Methods For The Treatment Of Her2 Amplified Cancer1
EP2529622
Jan 17, 2018Inhibitors Of Bruton'S Tyrosine Kinase1

Latest PTAB cases involving Pharmacyclics

Discover the latest PTAB cases involving Pharmacyclics, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Pharmacyclics

PGR2024-00009Nov 1, 2023BEIGENE USAPHARMACYCLICSFinal Written Decision
IPR2019-00865Mar 21, 2019SANDOZPHARMACYCLICSFinal Written Decision
IPR2015-01076Apr 20, 2015COALITION FOR AFFORDABLE DRUGS IVPHARMACYCLICSInstitution Denied

Peer Comparison New

IP litigation analysis comparing Pharmacyclics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
PHARMACYCLICS - 3 - 3
BEIGENE USA - - 1 -
COALITION FOR AFFORDABLE DRUGS IV - - 1 -
GENERICS UK214 - - -